Ionis Pharmaceuticals (IONS) Deferred Taxes (2018 - 2020)

Ionis Pharmaceuticals' Deferred Taxes history runs 3 years deep, the most recent figure standing at $340.1 million for Q4 2020.

• In Q4 2020, Deferred Taxes rose 10754.14% year-over-year to $340.1 million; the TTM figure through Sep 2021 stood at $340.1 million (up 22140.18% YoY), while the FY2020 annual figure was $341.7 million, up 37411.42% from the prior year.
• Deferred Taxes was $340.1 million for Q4 2020 at Ionis Pharmaceuticals, up from $1.5 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $340.1 million in Q4 2020 to a low of -$290.5 million in Q4 2018.
• Historically, Deferred Taxes has averaged $5.8 million across 3 years, with a median of $887000.0 in 2019.
• Biggest YoY gain for Deferred Taxes was 10754.14% in 2020; the steepest drop was 116.89% in 2020.
• A 3-year view of Deferred Taxes shows it stood at -$290.5 million in 2018, then surged by 98.9% to -$3.2 million in 2019, then surged by 10754.14% to $340.1 million in 2020.
• The last three Deferred Taxes figures came in at $340.1 million (Q4 2020), $1.5 million (Q3 2020), and $2.5 million (Q2 2020), per Business Quant data.